U.S. Patent issued for Histogen’s Novel Cell Growth Process
Histogen, Inc., a regenerative medicine company developing innovative therapies for conditions including hair loss and cancer, has been issued its first U.S. patent, covering the Company's method…
(PRWeb September 05, 2012)
Read the full story at http://www.prweb.com/releases/2012/9/prweb9867213.htmClick here for reuse options!
Copyright 2012 Biotechblog
Comments are closed.